Ankyrin Repeat and SOCS Box 3 (ASB3) Mediates Ubiquitination and Degradation of Tumor Necrosis Factor Receptor II

ABSTRACT Ankyrin repeat and SOCS box (ASB) family members have a C-terminal SOCS box and an N-terminal ankyrin-related sequence of variable repeats belonging to the SOCS superfamily. While SH2-domain-bearing SOCS proteins are mainly involved in the negative feedback regulation of the protein tyrosine kinase-STAT pathway in response to a variety of cytokines, the roles of ASB family members remain largely unknown. To investigate ASB functions, we screened for ASB3-interacting factors by using antibody array technology and identified tumor necrosis factor receptor II (TNF-R2) as an ASB3 binding target. ASB3 expression and activities are required for (i) TNF-R2 ubiquitination both in vivo and in vitro, (ii) TNF-R2 proteolysis via the proteasome pathway, and (iii) the inhibition of TNF-R2-mediated Jun N-terminal protein kinase (JNK) activation. While the ankyrin repeats of ASB3 interact with the C-terminal 37 amino acids of TNF-R2, the SOCS box of ASB3 is responsible for recruiting the E3 ubiquitin ligase adaptors Elongins-B/C, leading to TNF-R2 ubiquitination on multiple lysine residues within its C-terminal region. Downregulation of ASB3 expression by a small interfering RNA inhibited TNF-R2 degradation and potentiated TNF-R2-mediated cytotoxicity. The data presented here implicate ASB3 as a negative regulator of TNF-R2-mediated cellular responses to TNF-α by direct targeting of TNF-R2 for ubiquitination and proteasome-mediated degradation.

[1]  S. Smerdon,et al.  The ankyrin repeat: a diversity of interactions on a common structural framework. , 1999, Trends in biochemical sciences.

[2]  A. Kibel,et al.  Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C , 1995, Science.

[3]  Hao Wu,et al.  Structural basis for self-association and receptor recognition of human TRAF2 , 1999, Nature.

[4]  E. Tindall,et al.  Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. , 1997, The New England journal of medicine.

[5]  D. Goeddel,et al.  TNF-R1 Signaling: A Beautiful Pathway , 2002, Science.

[6]  J. Johnston,et al.  Cytokine‐inducible SH2 protein‐3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N‐terminal kinase inhibitory region as well as SH2 domain , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[7]  D. Goeddel,et al.  TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 , 1995, Science.

[8]  Y. E. Chin,et al.  Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB Activation , 2000, Molecular and Cellular Biology.

[9]  R. Beyaert,et al.  Function and regulation of tumor necrosis factor receptor type 2. , 2004, Current medicinal chemistry.

[10]  Jianren Gu,et al.  Molecular cloning and characterization of the human ASB-8 gene encoding a novel member of ankyrin repeat and SOCS box containing protein family. , 2003, Biochemical and biophysical research communications.

[11]  T. Naka,et al.  Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. M. McFarlane,et al.  Differential activation of nuclear factor‐κB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly , 2002, FEBS letters.

[13]  S. Ghosh,et al.  X-ray Crystal Structure of an IκBβ·NF-κB p65 Homodimer Complex* , 2003, Journal of Biological Chemistry.

[14]  L. Williams,et al.  Tumor necrosis factor α‐induced activation of c‐jun N‐terminal kinase is mediated by TRAF2 , 1997, The EMBO journal.

[15]  Yahong Lin,et al.  A JNK-dependent pathway is required for TNFalpha-induced apoptosis. , 2003, Cell.

[16]  H. J. Kim,et al.  Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. , 1998, Molecular cell.

[17]  R. Hartmann-Petersen,et al.  Transferring substrates to the 26S proteasome. , 2003, Trends in biochemical sciences.

[18]  W. Kaelin,et al.  The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. , 1998, Genes & development.

[19]  N. Fan,et al.  The p70 tumor necrosis factor receptor mediates cytotoxicity , 1992, Cell.

[20]  Jonathan S. Reichner,et al.  Antibodies Immobilized as Arrays to Profile Protein Post-translational Modifications in Mammalian Cells* , 2004, Molecular & Cellular Proteomics.

[21]  Yili Yang,et al.  TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2 , 2002, Nature.

[22]  M. Nussenzweig,et al.  TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. , 1997, Immunity.

[23]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[24]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[25]  M. Lenardo,et al.  A crucial role for p80 TNF‐R2 in amplifying p60 TNF‐R1 apoptosis signals in T lymphocytes , 2000, European journal of immunology.

[26]  S. Akira,et al.  Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.

[27]  J. Kutok,et al.  Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation , 2001, Molecular and Cellular Biology.

[28]  T. Espevik,et al.  Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities , 1994, European journal of immunology.

[29]  W. Alexander,et al.  Twenty proteins containing a C-terminal SOCS box form five structural classes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Yoshimura,et al.  The JAK‐binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop , 1999, The EMBO journal.

[31]  J. G. Zhang,et al.  The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Kaelin,et al.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. , 1999, Science.

[33]  R. Hartmann-Petersen,et al.  Ubiquitin-proteasome system , 2004, Cellular and Molecular Life Sciences CMLS.

[34]  George Kollias,et al.  The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.

[35]  M. Lenardo,et al.  Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.

[36]  P. Henkart,et al.  Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. , 1995, Journal of immunology.

[37]  Yahong Lin,et al.  A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis , 2003, Cell.